Spineway SA (EPA:ALSPW)

France flag France · Delayed Price · Currency is EUR
0.127
+0.003 (2.42%)
Feb 21, 2025, 5:35 PM CET
-94.71%
Market Cap 35.41M
Revenue (ttm) 11.99M
Net Income (ttm) -8.00M
Shares Out 278.82M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,794,510
Average Volume 3,455,432
Open 0.130
Previous Close 0.124
Day's Range 0.113 - 0.129
52-Week Range 0.073 - 6.400
Beta 1.50
RSI 62.34
Earnings Date Mar 24, 2025

About Spineway

Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; posterior osteosynthesis systems; kili, an anterior lumbar interbody fusion cage; twin peaks plif posterior lumbar interbody fus... [Read more]

Sector Healthcare
Founded 2005
Employees 54
Stock Exchange Euronext Paris
Ticker Symbol ALSPW
Full Company Profile

Financial Performance

In 2023, Spineway's revenue was 11.36 million, an increase of 31.34% compared to the previous year's 8.65 million. Losses were -6.51 million, 107.5% more than in 2022.

Financial Statements

News

There is no news available yet.